IFN-alpha as a time-sensitive biomarker during Oropouche virus infection in early and late seroconverters

Oliveira, Euzébio de; Azevedo, Raimunda do Socorro Silva; Reis, Jordana Grazziela Coelho Dos; Antonelli, Lis Ribeiro do Valle; Ferreira, Milene Silveira; Azevedo, Ana Carolina Campi; Silva, Matheus Fernandes Costa; Martins, Lívia Carício; Chiang, Jannifer Oliveira; Carvalho, Andréa Teixeira de; Martins Filho, Olindo Assis; Vasconcelos, Pedro Fernando Costa.
Artículo en Inglés | ARCA | ID: arc-57518

Documentos relacionados

  1. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder.
  2. Adenoviral gene therapy for bladder cancer.
  3. You Can Breathe Easy: IFNλ Handles Flu without Triggering a Damaging Inflammatory Response.
  4. Antibody-dependent enhancement and neutralization against CVB4 investigated in vitro and in silico through an agent-based model.
  5. From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.
  6. Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse.
  7. Differential effect of interferon-alpha treatment on AEA and 2-AG levels.
  8. [Precise immunological classification guidance for early initiation of antiviral therapy in patients with chronic HBV infection].
  9. Severe acute herpes virus type 2 primo-infection and its association with anti-type 1 interferon autoantibodies.
  10. Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).